MUC16 and familial pancreatic carcinoma: It has been shown that the rare (<2%) long-term (>10 years) survivors of pancreatic cancer carry infiltrating cytotoxic T cells specific for a MUC16 neo-epitope which cross-reacts with pathogen-associated epitopes [49].